Your browser doesn't support javascript.
loading
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024.
Ozaki, Yukio; Tobe, Akihiro; Onuma, Yoshinobu; Kobayashi, Yoshio; Amano, Tetsuya; Muramatsu, Takashi; Ishii, Hideki; Yamaji, Kyohei; Kohsaka, Shun; Ismail, Tevfik F; Uemura, Shiro; Hikichi, Yutaka; Tsujita, Kenichi; Ako, Junya; Morino, Yoshihiro; Maekawa, Yuichiro; Shinke, Toshiro; Shite, Junya; Igarashi, Yasumi; Nakagawa, Yoshihisa; Shiode, Nobuo; Okamura, Atsunori; Ogawa, Takayuki; Shibata, Yoshisato; Tsuji, Takafumi; Hayashida, Kentaro; Yajima, Junji; Sugano, Teruyasu; Okura, Hiroyuki; Okayama, Hideki; Kawaguchi, Katsuhiro; Zen, Kan; Takahashi, Saeko; Tamura, Toshihiro; Nakazato, Kazuhiko; Yamaguchi, Junichi; Iida, Osamu; Ozaki, Reina; Yoshimachi, Fuminobu; Ishihara, Masaharu; Murohara, Toyoaki; Ueno, Takafumi; Yokoi, Hiroyoshi; Nakamura, Masato; Ikari, Yuji; Serruys, Patrick W; Kozuma, Ken.
Afiliación
  • Ozaki Y; Department of Cardiology, Fujita Health University Okazaki Medical Center, Fujita Health University School of Medicine, 1-98 Dengaku, Kutsukake, Toyoake, Aichi, 470-1192, Japan. yukio.ozaki7@gmail.com.
  • Tobe A; Department of Cardiology, University of Galway, Galway, Ireland.
  • Onuma Y; Department of Cardiology, University of Galway, Galway, Ireland.
  • Kobayashi Y; Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Amano T; Department of Cardiology, Aichi Medical University, Nagakute, Japan.
  • Muramatsu T; Department of Cardiology, Fujita Health University Okazaki Medical Center, Fujita Health University School of Medicine, 1-98 Dengaku, Kutsukake, Toyoake, Aichi, 470-1192, Japan.
  • Ishii H; Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Yamaji K; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kohsaka S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Ismail TF; King's College London, London, UK.
  • Uemura S; Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.
  • Hikichi Y; Cardiovascular Medicine, Kawasaki Medical School, Kurashiki, Japan.
  • Tsujita K; Heart Center, Saga Medical Center Koseikan, Saga, Japan.
  • Ako J; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Morino Y; Department of Cardiology, Kitasato University Hospital, Sagamihara, Japan.
  • Maekawa Y; Department of Cardiology, Iwate Medical University Hospital, Shiwa, Japan.
  • Shinke T; Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Shite J; Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Igarashi Y; Cardiology Division, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Nakagawa Y; Division of Cardiology, Sapporo-Kosei General Hospital, Sapporo, Japan.
  • Shiode N; Division of Cardiovascular Medicine, Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.
  • Okamura A; Division of Cardiology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Ogawa T; Division of Cardiology, Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka, Japan.
  • Shibata Y; Division of Cardiology, The Jikei University School of Medicine, Tokyo, Japan.
  • Tsuji T; Division of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.
  • Hayashida K; Kusatsu Heart Center, Kusatsu, Japan.
  • Yajima J; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Sugano T; Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.
  • Okura H; Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
  • Okayama H; Department of Cardiology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Kawaguchi K; Division of Cardiology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Zen K; Department of Cardiology, Komaki City Hospital, Komaki, Japan.
  • Takahashi S; Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Tamura T; Division of Cardiology, Tokushukai Shonan Oiso Hospital, Oiso, Japan.
  • Nakazato K; Division of Cardiology, Tenri Hospital, Tenri, Japan.
  • Yamaguchi J; Department of Cardiology, Fukushima Medical University Hospital, Fukushima, Japan.
  • Iida O; Department of Cardiology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Ozaki R; Cardiovascular Division, Osaka Police Hospital, Osaka, Japan.
  • Yoshimachi F; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ishihara M; Department of Cardiology, Tokai University Hachioji Hospital, Hachioji, Japan.
  • Murohara T; Department of Cardiovascular and Renal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Ueno T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yokoi H; Division of Cardiology, Marin Hospital, Fukuoka, Japan.
  • Nakamura M; Cardiovascular Center, Fukuoka Sanno Hospital, Fukuoka, Japan.
  • Ikari Y; Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University School of Medicine, Tokyo, Japan.
  • Serruys PW; Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
  • Kozuma K; Department of Cardiology, University of Galway, Galway, Ireland.
Cardiovasc Interv Ther ; 2024 Sep 20.
Article en En | MEDLINE | ID: mdl-39302533
ABSTRACT
Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022. Recently, the European Society of Cardiology (ESC) published the guidelines for the management of acute coronary syndrome in 2023. Major new updates in the 2023 ESC guideline include (1) intravascular imaging should be considered to guide PCI (Class IIa); (2) timing of complete revascularization; (3) antiplatelet therapy in patient with high-bleeding risk. Reflecting rapid advances in the field, the Task Force on Primary PCI of the CVIT group has now proposed an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2024 version.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cardiovasc Interv Ther Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cardiovasc Interv Ther Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón